Datapublica
Log in

ORIFARM GENERICS A/S

CVR25674030

Core data

Name
ORIFARM GENERICS A/S
Address
Energivej 15, 5260, Odense S
Founded
Oct 15, 2000
255 / 219
Locations (P-units)
2View locations
Website
https://www.orifarm.com/our-business/denmark/
Branch
Engroshandel med læge- og hospitalsartikler (464620)

Keep track of ORIFARM GENERICS A/S

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

Orifarm Generics A/S is part of Orifarm Group, which is a dynamic international player in the healthcare business.​​Orifarm Generics A/S is selling generics pharmaceuticals. As such, the entity only has one segment, where products are sold within the two product platforms Specialty Rx and Consumer Healthcare.​ ​Specialty Rx​Off-patent, small molecule medicine sold via pharmacy substitution and hospital tendering (nGx) or prescribed by​physicians without substitution (pRx). ​ ​Consumer Healthcare​Products for health needs available without prescription; chosen by consumers; OTC regulated as pharmaceutical​with an API, while VMS is regulated as food supplements (no API).

Financials

View detailed financials
Company financials
Reporting period
2025DKK
Revenue
2,463,585,000
Gross profit
399,753,000
Operating profit
108,161,000
Profit before tax
98,857,000
Net income
77,177,000
Total assets
1,258,605,000
Equity
496,304,000
Avg. employees
247
2017–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

See plansLearn about Risk Score

Contact

From cvr.dk

Company
3315****Show full

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Birgitte Bøgh-SørensenRoles
Board
TitlesBESTYRELSESMEDLEM
Hans Carl Bøgh-SørensenRoles
Board
TitlesFORMAND
Mads Fink EriksenRoles
Board
TitlesBESTYRELSESMEDLEM
Nicki Lund KristensenRoles
Board
TitlesBESTYRELSESMEDLEM
Thomas BrandhofRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • ADM. DIR.

Auditor

Deloitte Statsautoriseret RevisionspartnerselskabAuditorJens SerupRoleState Authorised Public AccountantFromMay 28, 2026
Deloitte Statsautoriseret RevisionspartnerselskabAuditorNicolai Niemann DamtoftRoleState Authorised Public AccountantFromMay 28, 2026

Legal owners

View ownership diagram
ORIFARM GENERICS HOLDING A/S
Ownership100 %Voting rights100 %FromSep 10, 2004

Ultimate owners

View ownership diagram
Andreas Henrik Bøgh-Sørensen
Ownership through
HBS Capital ApSHABICO HOLDING A/SHABICO A/SOrifarm Holding A/SORIFARM GROUP A/SORIFARM GENERICS HOLDING A/S
Anheco Capital ApSHABICO HOLDING A/SHABICO A/SOrifarm Holding A/SORIFARM GROUP A/SORIFARM GENERICS HOLDING A/S
27.5–42.21 %
Anne-Charlotte Bille Brahe Selby
Ownership through
HBS Capital ApSHABICO HOLDING A/SHABICO A/SOrifarm Holding A/SORIFARM GROUP A/SORIFARM GENERICS HOLDING A/S
Acco Capital ApSHABICO HOLDING A/SHABICO A/SOrifarm Holding A/SORIFARM GROUP A/SORIFARM GENERICS HOLDING A/S
27.5–42.21 %
Christian Ulrik Munksgaard Bøgh-Sørensen
Ownership through
HBS Capital ApSHABICO HOLDING A/SHABICO A/SOrifarm Holding A/SORIFARM GROUP A/SORIFARM GENERICS HOLDING A/S
Chuco Capital ApSHABICO HOLDING A/SHABICO A/SOrifarm Holding A/SORIFARM GROUP A/SORIFARM GENERICS HOLDING A/S
27.5–42.21 %
Hans Carl Bøgh-Sørensen
Ownership through
HBS Capital ApSHABICO HOLDING A/SHABICO A/SOrifarm Holding A/SORIFARM GROUP A/SORIFARM GENERICS HOLDING A/S
7.5–13.33 %

Official sources

Open on VirkOpen at GLEIF